The FDA has granted an in-person Type C meeting during the first quarter of 2026 New independent analyses across large observational ALS cohorts ...
Canada revised its medical assistance in dying (MAiD) legislation to extend eligibility to individuals without a reasonably foreseeable natural death (Track 2). We sought to describe the clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback